|
|
|
| GMC guidance on end of life care (editorial) | |
| Bell D |
| BMJ 2010;340:c3231
[]
[] | |
|
| Cannabis based drug is licensed for spasticity in patients with MS (news) | |
| Kmietowicz Z |
| BMJ 2010;340:c3363
[]
[] | |
|
| Possible misuse of "palliative care" coding (comment) | |
| Clearkin RJ |
| BMJ 2010;340:c2753
[]
[] | |
|
| Pharmacological management of neuropathic pain in non-specialist settings... (practice guideline) | |
| Tan T, Barry P, Reken S, Baker M, On behalf of the Guideline Development Group |
| BMJ 2010;340:c1079
[]
[] | |
|
| Assisted suicide: a substitute for a caring doctor? | |
| Livesley B |
| BMJ 2010;340:c1590
[]
[] | |
|
| The impact of advance care planning on end of life care in elderly... (randomized controlled trial) | |
| Detering KM, Hancock AD, Reade MC, Silvester W |
| BMJ 2010;340:c1345 []
[]
[] | |
|
| Doctors and assisted suicide (editorial) | |
| Coggon J |
| BMJ 2010;340:c1394
[]
[] | |
|
| Interaction of serotonin reuptake inhibitors with tamoxifen (comment) | |
| Andersohn F, Willich SN |
| BMJ 2010;340:c783
[]
[] | |
|
| Venlafaxine and cardiovascular toxicity (comment) | |
| Taylor D |
| BMJ 2010;340:c411
[]
[] | |
|
| Use of venlafaxine compared with other antidepressants and the risk of... (multicenter study) | |
| Martinez C, Assimes TL, Mines D, Dell'aniello S, Suissa S |
| BMJ 2010;340:c249 []
[]
[] | |
|
| Osteonecrosis of the jaw and bisphosphonates (editorial) | |
| Khan A |
| BMJ 2010;340:c246
[] | |
|
|